F-group (family)
212.1.1.18 Lon_C
Ligands and drugs
717
Member domains
97
with ligand contacts (≤ 4 Å)
13.5% of members
72
with DrugDomain annotations
10.0% of members
57
with a DrugBank compound
7.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 212.1.1.18 belongs to X-group 212 Ribosomal protein S5 domain 2-like, which binds 9.4 ligand superclasses per 20 proteins, broader than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00188 | BO2 | Bortezomib | 21 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 4KZ | N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 36 |
| BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 21 |
| NAmetal | SODIUM ION | 2 |
| UFY | N-[(1R)-1-borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide | 2 |
| UKS | [(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid | 2 |
| MGmetal | MAGNESIUM ION | 1 |